Diagnostic panels for BCP-ALL should include B-cell lineage specific antigens (CD19, CD10, CD20) and other markers useful for ALL subclassification and indicating clinically important abnormalities [9]. This evidence concerns the gene CD19 and acute lymphoblastic leukemia.